|
|
||||||||
POINT-COUNTERPOINT
O2 of 22% in HTx recipients receiving chronotropic support with a rate-responsive pacemaker. Pacing of the allograft in synchrony with the intrinsic depolarization rate of the native SA node may not be coupled to the dynamic metabolic demands of exercise, perhaps explaining why another study could not confirm the same benefit (9). In the absence of larger trials using chronotropic support, the issue of possible beneficial effects of exercise capacity by artificial enhancement of heart rate may seem unanswered. REFERENCES
| ||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |